EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Müller glia-derived pseudohypoxia drives intraretinal ischemic vasculopathy and neurovascular dysfunction

Hannah F Hu iD, Justin Yun, Aykut Demirkol, Xuan Cui, Siyuan Liu, Stephen H Tsang

Disease Models & Mechanisms · 29.10.2026

DOI: 10.1242/dmm.052889 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Disease Models & Mechanisms, online erschienen am 29.10.2026. Verfasst von Hannah F Hu und 5 weiteren Autor:innen. Beteiligte Einrichtung: Jonas Children's Vision Care and Bernard & Shirlee Brown Glaucoma Laboratory, Institute of Human Nutrition, Columbia Stem Cell Initiative, New York, …. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Ischemic retinopathies are characterized by retinal vascular instability, increased vascular permeability, and progressive neurovascular dysfunction. However, the cell-type-specific mechanisms initiating these changes remain insufficiently defined. Müller glia are central regulators of retinal metabolic homeostasis and a major source of vascular endothelial growth factor (VEGF), which positions them as potential upstream drivers of ischemia-associated vascular pathology. Here, we describe a conditional genetic mouse model in which pseudohypoxic signaling is selectively induced in Müller glia through tamoxifen-inducible deletion of von Hippel-Lindau (Vhl) using an Slc1a3-CreER driver. Müller glia-targeted Vhl deletion resulted in robust upregulation of retinal VEGF, intraretinal microvascular abnormalities, focal vascular leakage, corneal hemorrhaging, and microaneurysms. Functional assessment revealed transient inner retinal electroretinographic deficits without overt neuronal loss, consistent with early neurovascular dysfunction. Collectively, these findings demonstrate that glial hypoxia signaling via Vhl knockout is sufficient to induce retinal ischemic vasculopathy reflective of clinical phenotypes, providing a tractable platform for dissecting glial contributions to retinal vascular disease.

Schlagwörter

Stichwörter der Autor:innen

Ischemic retinopathyMuller glial cellsPreclinical Mouse Model

Autor:innen und Institutionen

  • Jonas Children's Vision Care and Bernard & Shirlee Brown Glaucoma Laboratory, Institute of Human Nutrition, Columbia Stem Cell Initiative, New York, NY, USA.
  • Department of Biomedical Engineering, Columbia University, New York, NY, USA.
  • Edward S. Harkness Eye Institute, Columbia University Irving Medical Center, New York-Presbyterian Hospital, New York, NY, USA.
  • Departments of Ophthalmology, Pathology & Cell Biology, Vagelos College of Physicians and Surgeons, Columbia University Irving Medical Center, New York, NY, USA.
  • Vocational School of Health Services, Uskudar University, 34672 Istanbul, Turkey.
  • New England College of Optometry, Boston, MA, USA.

ORCID-Profile: Hannah F Hu

Zitieren

APA

Hu, H. F., Yun, J., Demirkol, A., Cui, X., Liu, S., & Tsang, S. H. (2026). Müller glia-derived pseudohypoxia drives intraretinal ischemic vasculopathy and neurovascular dysfunction. Disease Models & Mechanisms. https://doi.org/10.1242/dmm.052889

Vancouver

Hu HF, Yun J, Demirkol A, Cui X, Liu S, Tsang SH. Müller glia-derived pseudohypoxia drives intraretinal ischemic vasculopathy and neurovascular dysfunction. Disease Models & Mechanisms. 2026. doi:10.1242/dmm.052889

BibTeX
@article{Hu2026,
  author = {Hu, Hannah F and Yun, Justin and Demirkol, Aykut and Cui, Xuan and Liu, Siyuan and Tsang, Stephen H},
  title = {Müller glia-derived pseudohypoxia drives intraretinal ischemic vasculopathy and neurovascular dysfunction},
  journal = {Disease Models & Mechanisms},
  year = {2026},
  doi = {10.1242/dmm.052889}
}
Kostenlos starten →